Summary:
The purpose of this study is to compare the long-term joint safety and efficacy (pain relief) of the investigational study drug, tanezumab compared to non-steroidal anti inflammatory drugs (NSAIDs) in subjects with osteoarthritis of the hips or knees.
Qualified Participants Must:
• Be 18 years of age or older
•
Have a diagnosis of osteoarthritis of the index hip or knee
•
Currently be receiving a stable dose regimen of oral NSAID (naproxen, celecoxib or diclofenac)
Qualified Participants May Receive:
study-related medical care and investigational medication at no cost and may be compensated for time and travel.